Experimental Vaccine Targets Genital Cancer

Links shared publicly online about this topic.

  • 1,626
    total visits

Experimental Vaccine Targets Genital Cancer

webmd.com

An experimental human papilloma virus (HPV) vaccine shows early promise for preventing genital cancer in high-risk women who are already infected with the virus.

View full resource at webmd.com

Tags: Vaccination, Wart, STD, HPV, Cancer, Cervical Cancer Prevention, Vaccine, HPV Vaccine

  • Share

Most Recently Shared on November 5, 2009 at 8:41 pm By:

WebMD WebMD

An experimental HPV vaccine shows early promise for preventing genital cancer in high-risk women who already carry HPV. http://bit.ly/1DBwu2

3 years ago...

Also Shared By:

WebMD_News WebMD_News

Health Feed Health Feed

Researchers target multiple tumors in new cancer vaccine study - FierceVaccines

fiercevaccines.com — “Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or Read more...View full resource at fiercevaccines.com

  • View Related
  • Share

Most Recently Shared on January 26, 2012 at 2:06 pm By:

FiercePharma FiercePharma Health Site

RT @FierceBiotech: Future threat to Provenge? New cancer vax study targets multiple tumors (prostate, lung, etc) http://t.co/oCAnW1wj

4 months ago...

UPDATE 3-UK switches to Merck's Gardasil for HPV vaccination | Reuters

reuters.com — “* GSK's Cervarix dropped as focus changes in HPV programme* UK now targeting genital warts as well as cervical cancer* Win for Gardasil underlines its lead in global market* GSK says chose not to participateView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 24, 2011 at 6:01 pm By:

Cancer Vaccine Shows Early Promise - ABC News

abcnews.go.com — “A new experimental cancer vaccine that targets the immune system has shown some early progress in improving survival in women with metastatic breast or ovarian cancer. Researchers at the Center for Cancer Research, the National Cancer Institute and the National Institutes of Health tested a vaccine called Panvac in 26 women with breast or ovarian cancer that had spread to other parts of their bodies and had  progressively worsened after chemotherapy. Some weren’t candidates for standaView full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on November 8, 2011 at 10:00 pm By:

Cancer_Wisdom Cancer OW OW Health

Cancer Vaccine Shows Early Promise: A new experimental cancer vaccine that targets the immune system has shown s... http://t.co/rUvcgx9r

7 months ago...

Experimental Vaccine Against Breast, Ovarian Cancer Shows Promise - - TIME Healthland

healthland.time.com — “Dispatching cancer cells with the same precision that vaccines dismiss bacteria and viruses may soon be possible, according to scientists at the National Cancer Institute who are working on an experimental vaccine that helps the immune system target breast and ovarian cancer cells.View full resource at healthland.time.com

  • View Related
  • Share

Most Recently Shared on November 8, 2011 at 9:15 pm By:

TIMEHealthland TIMEHealthland Health Site

An experimental injection that targets breast and ovarian cancer shows promise | http://t.co/JJNsQqYh

7 months ago...

Vaccine study supports immune targeting of brain tumors

sciencedaily.com — “An experimental vaccine targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on June 17, 2011 at 1:43 pm By:

Vaccine Study Supports Immune Targeting Of Brain Tumors

medicalnewstoday.com — “An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves lView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 16, 2011 at 2:05 pm By:

mnt_neurology MNT Neurology News Neurology and Health News

Vaccine Study Supports Immune Targeting Of Brain Tumors http://mnt.to/3Xhq #neurology

11 months ago...

Vaccine Study Supports Immune Targeting of Brain Tumors

newswise.com — “An experimental vaccine developed by researchers at Cedars-Sinai Medical Center’s Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on June 16, 2011 at 1:44 pm By:

mednewswise Thom Canalichio Health News

Vaccine Study Supports Immune Targeting of Brain Tumors: An experimental vaccine developed by researcher... http://bit.ly/lau6Vg #cancer

11 months ago...

Experimental vaccine cures pre-cancer vulvar growths | Reuters

feeds.reuters.com — “BOSTON (Reuters) - An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the NetherlandsView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on November 5, 2009 at 10:27 am By:

Reuters_Health Reuters Health Health News

Experimental vaccine cures pre-cancer vulvar growths http://link.reuters.com/hud87f

3 years ago...

Experimental vaccine cures pre-cancer vulvar growths | Reuters

reuters.com — “BOSTON (Reuters) - An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the NetherlandsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 5, 2009 at 10:26 am By:

Health_Feed Health Feed Health News

#HEALTH Experimental vaccine cures pre-cancer vulvar growths - Reuters http://ow.ly/15ZArT

3 years ago...

Advertisement